C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1989
10/31/1989	US4877867 Antibodies for the detection of mammalian ras gene products, method of preparing and method of using same
10/31/1989	US4877865 Bovine interferon
10/31/1989	US4877864 Osteoinductive factors
10/31/1989	US4877729 Blood cell growth stimulants
10/31/1989	US4877614 Biologically active fragments of human antihemophilic factor and method for preparation thereof
10/31/1989	US4877613 Precipitation of surface polysaccharide by complexing with cationic compound
10/31/1989	US4877608 Sodiuum chloride and-or potassium chloride, lysine hydrochloride, and histidine
10/31/1989	CA1262533A1 High level production of swine growth hormone
10/31/1989	CA1262532A1 Composition useful for the production of vaccines containing particles with the surface antigen of the hepatitis b virus and the receptor of the polymerized human serum albumin, animal cells capable of producing such particles and process for their obtention
10/25/1989	EP0339009A2 Method for improving the efficacy of insect toxins
10/25/1989	EP0338916A1 Haemoglobin macromolecular complexes, method of preparation and their uses
10/25/1989	EP0338846A2 Monoclonal antibodies
10/25/1989	EP0338767A2 Novel recombinant and chimeric antibodies directed against a human adenocarcinoma antigen
10/25/1989	EP0338745A1 Method for producing recombinant DNA proteins
10/25/1989	EP0338713A1 Diagnosis of chronic myelogenous leukemia
10/25/1989	EP0338634A2 Viper venom polypeptides and genetic expression
10/25/1989	EP0338620A1 Recovery of hepatitis B surface antigen
10/25/1989	EP0338566A2 Pertussis toxoid vaccine
10/25/1989	EP0338437A2 Synthetic vaccins against foot and mouth disease and their preparation process
10/25/1989	EP0338436A2 Monoclonal antibody against neuropeptide Y, method for its preparation as well as its use
10/25/1989	EP0338395A2 Monoclonal antibodies to Pseudomonas aeruginosa, their production and use
10/25/1989	EP0338265A2 Haemophilus influenzae type B polysaccharide-outer membrane protein conjugate vaccine
10/25/1989	EP0338170A1 Immunoprotective antigenic protein against pathogenic bacteria
10/25/1989	EP0338169A1 Method for obtaining protective antigens against bordetella infections and toxic processes
10/25/1989	EP0259455A4 Nephritis strain associated protein.
10/25/1989	EP0192657B1 Monoclonal antibody directed to human ganglioside gd 2?
10/24/1989	US4876367 Macrocyclic polyether carboxylic acids
10/24/1989	US4876332 Heparin binders; cellular adhesion promoters; coatings for medical equipment and bandages
10/24/1989	US4876242 Human insulin-like growth factor analoges with reduced binding to serum carrier proteins and their production in yeast
10/24/1989	US4876197 Gene expression in yeast; genetic engineering
10/24/1989	US4876194 Protein L and subfragments thereof, with immunoglobulin binding activity, a process for preparing thereof, reagent kit, pharmaceutical composition and a peptococcus magnus strain
10/24/1989	US4876186 Detection and differentiation of coxiella burnetii in biological fluids
10/24/1989	US4876089 Envelope glycoprotein
10/24/1989	US4876081 Coupling to proteins, polypeptids; diagnostic and therapy compounds
10/19/1989	WO1989009834A1 Calcium channel compositions and methods
10/19/1989	WO1989009831A1 Lak cell cytotoxin
10/19/1989	WO1989009829A2 Methods of generating desired amino-terminal residues in proteins
10/19/1989	WO1989009825A1 Method for producing recombinant dna proteins
10/19/1989	WO1989009824A2 Gene synthesis
10/19/1989	WO1989009822A1 Method for the in-vivo production and testing of proteins by recombinant gene expression in selected host-cells
10/19/1989	WO1989009819A1 Combining mutations for stabilization of subtilisin
10/19/1989	WO1989009818A1 Processes for purifying phospholipase a2 and producing phospholipase a2-like polypeptides
10/19/1989	WO1989009815A1 Novel virus of the hiv-2 family and methods of detection therefor
10/19/1989	WO1989009792A1 Method for potentiating and inhibiting insulin-like growth factor activity
10/19/1989	WO1989009791A1 Dna encoding androgen receptor protein
10/19/1989	WO1989009788A2 Biosynthetic osteogenic proteins and osteogenic devices containing them
10/19/1989	WO1989009787A2 Osteogenic devices
10/19/1989	WO1989009786A1 Peptide derivatives
10/19/1989	WO1989009785A1 Peptides inhibitors of hiv induced cell fusions and syncytia formation
10/19/1989	WO1989009784A1 Production of heat-stable factor viii concentrate
10/19/1989	WO1989009783A1 Polypeptides stabilized by covalent hydrogen bond replacements
10/19/1989	WO1989009782A1 New anti-receptor peptides and therapeutic agents
10/19/1989	WO1989009777A1 Methods and materials relating to dna binding proteins
10/19/1989	WO1989009776A1 VirE OPERON-ENCODED POLYPEPTIDES THAT BIND SINGLE-STRANDED DNA
10/19/1989	WO1989009622A1 Il-2 receptor-specific chimeric antibodies
10/19/1989	WO1989009621A2 Compounds for diagnosis and/or therapy of tumours
10/19/1989	WO1989009618A1 Method for controlling hiv infectivity and vaccines for use therein
10/19/1989	WO1989009617A1 A pasteurella vaccine
10/19/1989	WO1989009612A1 FACTOR VII/VIIa ACTIVE SITE INHIBITORS
10/19/1989	WO1989009611A1 Cyclic analogs of atrial natriuretic peptides
10/19/1989	WO1989009606A1 Pharmaceutical for treating tumors in humans and method for making it
10/19/1989	WO1989009605A1 Bone-inducing protein
10/19/1989	WO1989009542A1 Azido-substituted octopamine agonists and the use thereof to control invertebrate pests
10/19/1989	WO1989009227A3 Pf10 to pf19 peptides of an hiv retrovirus, process for synthetizing said peptides and their use, in particular for diagnosis
10/19/1989	WO1989008657A3 Preparation of nitruro compounds usable as radio-pharmaceutical products
10/19/1989	DE3910667A1 Peptide derivatives
10/19/1989	DE3910323A1 Biologically active proteins
10/19/1989	DE3811193A1 Peptides, process for their preparation and pharmaceutical compositions containing these peptides
10/18/1989	EP0337799A2 14-Beta-gal mammalian lectins
10/18/1989	EP0337750A1 Arcelin seed storage proteins from phaseolus vulgaris
10/18/1989	EP0337731A2 Peptide antibiotics
10/18/1989	EP0337714A2 HIV protease inhibitors useful for the treatment of aids
10/18/1989	EP0337604A1 Novel Bacillus thuringiensis gene encoding a coleopteran active toxin
10/18/1989	EP0337589A2 Recombinant and native group B eimeria tenella immunogens useful as coccidiosis vaccines
10/18/1989	EP0337532A1 Recombinant DNA; transformed microorganisms, plant cells and plants; a process for introducing an inducible property in plants, and a process for producing a polypeptide or protein by means of plants or plant cells
10/18/1989	EP0337498A2 Method for determining state of disease progression
10/18/1989	EP0337492A1 Purification of hepatitis proteins
10/18/1989	EP0337430A2 Antitumor antibiotic kedarcidin
10/18/1989	EP0337359A2 Lymphokine production and purification
10/18/1989	EP0337334A2 Renin-inhibiting amino acid derivatives
10/18/1989	EP0337295A2 Renin-inhibiting N-heterocyclic dipeptides
10/18/1989	EP0337264A2 Method for the production of proteins beginning their N-terminus with proline
10/18/1989	EP0337243A1 Process for purifying recombinant human interleukin-2
10/18/1989	EP0337203A2 Aglycons of A/16686 antibiotics
10/18/1989	EP0336956A1 Defective recombinant gene which can be activated by a transactivator
10/18/1989	EP0195817B1 Carboxyalkyldipeptides, their preparation and pharmaceutical compositions containing them
10/18/1989	CN1036332A Wound healing
10/18/1989	CN1036305A Fruit specific transcriptional factors
10/17/1989	US4874853 Detect fusion rna
10/17/1989	US4874845 T lymphocyte receptor subunit
10/17/1989	US4874746 Mixture of transforming growth factor alpha and platelet-derived growth factor
10/17/1989	US4874743 Antiinflammatory agents
10/17/1989	US4874705 Immunizing chickens
10/17/1989	US4874703 Animal growth regulators
10/17/1989	US4874702 Vectors and methods for making such vectors and for expressive cloned genes
10/17/1989	US4874697 Protease deficient mutant; producing protein or polypeptide with increased interferon activity
10/17/1989	US4874616 Method for producing mucoid and phage resistant group N streptococcus strains from non-mucoid and phage sensitive parent strains
10/17/1989	CA1262399A1 Gnrh antagonists
10/17/1989	CA1262333A1 Using monoclonal antibodies specific for treponema bacterial pathogens
10/11/1989	EP0336779A2 Polypeptides stabilized by covalent hydrogen bond replacements

1 ... 2810 2811 2812 2813 2814 2815 2816 2817 2818 2819 2820 2821 2822 2823 2824 2825 2826 2827 2828 2829 2830 ... 2916